1988 …2024

Research activity per year

Personal profile


I trained in haematology and general medicine in Belfast and then in the Royal Postgraduate Medical school, Hammersmith Hospital. I was appointed senior lecturer in 1991 and have been an active researcher and clinician in haematological malignancy in Belfast since that time.


Key Words
Myeloproliferative Disorders, Polycythaemia Vera, Idiopathic Erythrocytosis, Acute Myeloid Leukaemia, Chronic Myeloid Leukaemia and Clinical Trials.

I have received funding for Clinical Training Fellows from the Medical Research Council, Leukaemia Research Fund and the Research and Development Office Northern Ireland.

Research Statement

My main research interests are in myeloproliferative disorders, acute myeloid leukaemia and chronic myeloid leukaemia. I have an active clinical practice and collaborate with scientists looking at the pathogenesis of the myeloproliferative disorders and in particular investigations of patients with idiopathic erythrocytosis. I also work on the pathogenesis and treatment of Acute Myeloid Leukaemia and Chronic Myeloid Leukaemia.

Clinical Trials
With the clinical trials unit we have a number of phase three and phase two trials in the areas of acute myeloid leukaemia and chronic myeloid leukaemia and myeloproliferative disorders. We continually investigate for new and improved treatments in these disorders.

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being


Dive into the research topics where Mary Frances McMullin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or